Metformin Vitabalans

Metformin, the active ingredient in Metformin Vitabalans, is a biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans is an oral antidiabetic that acts on glucose metabolism in type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin may cause a range of adverse reactions, from mild gastrointestinal symptoms to rare but serious conditions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste. - Loss of appetite: reduced desire to eat. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Lactic acidosis: life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas.

Metformin requires careful monitoring in several clinical situations.

- Renal function assessment: avoid use in severe renal impairment. - Hepatic function monitoring: caution in patients with liver disease. - Lactic acidosis risk: discontinue before surgeries or contrast studies. - Vitamin B12 monitoring: periodic testing during long‑term therapy. - Pregnancy and breastfeeding: evaluate risk‑benefit with prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis. - Cimetidine: may raise metformin plasma concentrations. - Alcohol: potentiates lactic acidosis risk. - Didanosine: heightened risk of mitochondrial toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium. - Warfarin: occasional changes in INR may occur. - Thyroid hormones: may require dose adjustments of metformin.